6 Results for "

imidazopyrazines

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "imidazopyrazines" in MCE Product Catalog:

Cat. No.: HY-12912
CAS No.: 1513879-19-0
Purity:  99.42%
Target:  

PI4K Parasite

Research Areas:  

Infection

KDU691, an imidazopyrazine with potent anti-parasitic activity against blood stage schizonts, gametocytes and liver stages, is a Plasmodium PI4K inhibitor. KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites .
loading...
    loading...
Cat. No.: HY-124646
CAS No.: 1937235-76-1
Purity:  98.33%
Target:  

IRE1

Research Areas:  

Inflammation/Immunology

KIRA-7, an imidazopyrazine compound, binds the IRE1α kinase (IC50 of 110 nM) to allosterically inhibit its RNase activity. KIRA-7 has an anti-fibrotic effect .
loading...
    loading...
Cat. No.: HY-W062695
CAS No.: 1952316-43-6
Synonyms: (R)-ACP-196
Target:  

Btk

Research Areas:  

Cancer

(R)-Acalabrutinib ((R)-ACP-196) is the enantiomer of Acalabrutinib (HY-17600). (R)-Acalabrutinib is an inhibitor for Bruton’s tyrosine kinase (BTK) .
loading...
    loading...
Cat. No.: HY-155843
Research Areas:  

Infection

CDK9-IN-25 (compound 4a) is an imidazopyrazine CDK9 inhibitor (IC50: 0.24 μM). CDK9-IN-25 has good affinity to the main protease of COVID-19 and has antiviral activity against human coronavirus 229E (IC50: 63.28 μM) .
loading...
    loading...
Cat. No.: HY-W782935
CAS No.: 1195065-29-2
Target:  

MAPKAPK2 (MK2)

Research Areas:  

Inflammation/Immunology

MAPKAPK5-IN-1 is a substitutedtriazolopyrazine or imidazopyrazine compound and MAPKAPK5 inhibitor.MAPKAPK5-IN-1 can be used for the research of rheumatoid arthritis .
loading...
    loading...
Cat. No.: HY-18746
CAS No.: 1513879-18-9
Target:  

Parasite PI4K

Research Areas:  

Infection

KAI-407 is an orally active inhibitor of Plasmodium PI4K kinase, which can broadly inhibit multiple stages of the parasite lifecycle. KAI-407 exhibits EC50s of for the blood stage of malignant Plasmodium of 81 nM; for the liver schizonts of P. yoelii of 88 nM; and IC50s for the liver schizonts and dormant bodies of P. cynomolgi of 0.64 μM and 0.69 μM respectively. KAI-407 can prevent Plasmodium berghei infection 100%. KAI-407 can be used for the study of vivax malaria .
loading...
    loading...